Stockreport

SELLAS to Host Conference Call Following Oral Presentation of Phase 2b Results of NeuVax™ + Herceptin® to Prevent Breast Cancer Recurrence at the European Society for Medical Oncology (ESM...

SELLAS Life Sciences Group, Inc.  (SLS) 
Last sellas life sciences group, inc. earnings: 11/14 04:41 pm Check Earnings Report
PDF Interim and Updated Final Clinical Data to be Presented Conference Call on October 22, 2018 at 8:00 a.m. ET NEW YORK, Oct. 15, 2018 (GLOBE NEWSWIRE) -- SELLAS Life S [Read more]